Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.

导出原文传递

翻译打印收藏纠错

作者： Wenyin,Shi ^[1] ; Erik S,Blomain ^[2] ; Joshua,Siglin ^[3] ; Joshua D,Palmer ^[4] ; Tu,Dan ^[5] ; Yang,Wang ^[6] ; Maria,Werner-Wasik ^[7] ; Jon,Glass ^[8] ; Lyndon,Kim ^[8] ; Voichita,Bar Ad ^[7] ; Deepak,Bhamidipati ^[9] ; James J,Evans ^[8] ; Kevin,Judy ^[8] ; Christopher J,Farrell ^[8] ; David W,Andrews ^[8]

作者单位： Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. Wenyin.Shi@jefferson.edu. ^[1] Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, PA, USA. ^[2] Department of Radiation Oncology, University of Pittsburgh Medical Center, Altoona Cancer Center, Altoona, PA, USA. ^[3] Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. ^[4] Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA. ^[5] Cyberknife Center, Huashan Hospital Pudong, Fudan University, Shanghai, China. ^[6] Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. ^[7] Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA. ^[8] Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. ^[9]

关键词 Bevacizumab Glioblastoma High grade glioma Re-irradiation Stereotactic radiation